APO Research
Talk to an analyst

APO RESEARCH · REPORT

Doxorubicin Hydrochloride

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Doxorubicin Hydrochloride Industry Growth and Trends Forecast to 2032

31 December 202590 pages

Choose your research edition.

Industry ResearchDoxorubicin Hydrochloride Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Doxorubicin Hydrochloride Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Doxorubicin Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Doxorubicin Hydrochloride Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Doxorubicin Hydrochloride Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Doxorubicin Hydrochloride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Doxorubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Doxorubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Doxorubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Doxorubicin Hydrochloride include Medac GmbH, Sun Pharmaceutical, Viatris, Fresenius Kabi, Zhejiang Hisun (HanHui Pharmaceuticals), Pfizer, Shanxi PUDE Pharmaceutical, Shenzhen Main Luck Pharmaceuticals and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Doxorubicin Hydrochloride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Doxorubicin Hydrochloride market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Doxorubicin Hydrochloride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Doxorubicin Hydrochloride.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Doxorubicin Hydrochloride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Doxorubicin Hydrochloride Market by Company

Medac GmbH

Sun Pharmaceutical

Viatris

Fresenius Kabi

Zhejiang Hisun (HanHui Pharmaceuticals)

Pfizer

Shanxi PUDE Pharmaceutical

Shenzhen Main Luck Pharmaceuticals

Teva

Doxorubicin Hydrochloride Segment by Type

10mg

20mg

50mg

200mg

Others

Doxorubicin Hydrochloride Segment by Application

Malignant Lymphoma

Lung Cancer

Acute Leukemia

Breast Cancer

Others

Doxorubicin Hydrochloride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Doxorubicin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Doxorubicin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Doxorubicin Hydrochloride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Doxorubicin Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Doxorubicin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 20mg Table 3. Major Company of 50mg Table 4. Major Company of 200mg Table 5. Major Company of Others Table 6. Global Doxorubicin Hydrochloride Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 8. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Type (2021-2026) Table 9. Global Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 10. Global Doxorubicin Hydrochloride Sales Market Share in Value by Type (2021-2026) Table 11. Global Doxorubicin Hydrochloride Price by Type (2021-2026) & (US$/Unit) Table 12. Global Doxorubicin Hydrochloride Sales by Type (2027-2032) & (K Units) Table 13. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Type (2027-2032) Table 14. Global Doxorubicin Hydrochloride Sales by Type (2027-2032) & (US$ Million) Table 15. Global Doxorubicin Hydrochloride Sales Market Share in Value by Type (2027-2032) Table 16. Global Doxorubicin Hydrochloride Price by Type (2027-2032) & (US$/Unit) Table 17. North America Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 18. North America Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 20. Europe Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 24. Latin America Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Doxorubicin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Doxorubicin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 27. Doxorubicin Hydrochloride Industry Trends Table 28. Doxorubicin Hydrochloride Industry Drivers Table 29. Doxorubicin Hydrochloride Industry Opportunities and Challenges Table 30. Doxorubicin Hydrochloride Industry Restraints Table 31. Global Doxorubicin Hydrochloride Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Doxorubicin Hydrochloride Revenue Market Share by Company (2021-2026) Table 33. Global Doxorubicin Hydrochloride Sales by Company (2021-2026) & (K Units) Table 34. Global Doxorubicin Hydrochloride Sales Share by Company (2021-2026) Table 35. Global Doxorubicin Hydrochloride Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Doxorubicin Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Doxorubicin Hydrochloride Major Company Production Sites and Headquarters Table 38. Global Doxorubicin Hydrochloride Company, Product Type & Application Table 39. Global Doxorubicin Hydrochloride Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Doxorubicin Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Doxorubicin Hydrochloride Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Doxorubicin Hydrochloride Sales by Region (2021-2026) & (K Units) Table 44. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Region (2021-2026) Table 45. Global Doxorubicin Hydrochloride Sales by Region (2021-2026) & (US$ Million) Table 46. Global Doxorubicin Hydrochloride Sales Market Share in Value by Region (2021-2026) Table 47. Global Doxorubicin Hydrochloride Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Doxorubicin Hydrochloride Sales by Region (2027-2032) & (K Units) Table 49. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Region (2027-2032) Table 50. Global Doxorubicin Hydrochloride Sales by Region (2027-2032) & (US$ Million) Table 51. Global Doxorubicin Hydrochloride Sales Market Share in Value by Region (2027-2032) Table 52. Global Doxorubicin Hydrochloride Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Doxorubicin Hydrochloride Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 55. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Application (2021-2026) Table 56. Global Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 57. Global Doxorubicin Hydrochloride Sales Market Share in Value by Application (2021-2026) Table 58. Global Doxorubicin Hydrochloride Price by Application (2021-2026) & (US$/Unit) Table 59. Global Doxorubicin Hydrochloride Sales by Application (2027-2032) & (K Units) Table 60. Global Doxorubicin Hydrochloride Sales Market Share in Volume by Application (2027-2032) Table 61. Global Doxorubicin Hydrochloride Sales by Application (2027-2032) & (US$ Million) Table 62. Global Doxorubicin Hydrochloride Sales Market Share in Value by Application (2027-2032) Table 63. Global Doxorubicin Hydrochloride Price by Application (2027-2032) & (US$/Unit) Table 64. North America Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 65. North America Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 67. Europe Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 71. Latin America Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Doxorubicin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Doxorubicin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 74. Medac GmbH Company Information Table 75. Medac GmbH Business Overview Table 76. Medac GmbH Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Medac GmbH Doxorubicin Hydrochloride Product Portfolio Table 78. Medac GmbH Recent Development Table 79. Sun Pharmaceutical Company Information Table 80. Sun Pharmaceutical Business Overview Table 81. Sun Pharmaceutical Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sun Pharmaceutical Doxorubicin Hydrochloride Product Portfolio Table 83. Sun Pharmaceutical Recent Development Table 84. Viatris Company Information Table 85. Viatris Business Overview Table 86. Viatris Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Viatris Doxorubicin Hydrochloride Product Portfolio Table 88. Viatris Recent Development Table 89. Fresenius Kabi Company Information Table 90. Fresenius Kabi Business Overview Table 91. Fresenius Kabi Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Fresenius Kabi Doxorubicin Hydrochloride Product Portfolio Table 93. Fresenius Kabi Recent Development Table 94. Zhejiang Hisun (HanHui Pharmaceuticals) Company Information Table 95. Zhejiang Hisun (HanHui Pharmaceuticals) Business Overview Table 96. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product Portfolio Table 98. Zhejiang Hisun (HanHui Pharmaceuticals) Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pfizer Doxorubicin Hydrochloride Product Portfolio Table 103. Pfizer Recent Development Table 104. Shanxi PUDE Pharmaceutical Company Information Table 105. Shanxi PUDE Pharmaceutical Business Overview Table 106. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product Portfolio Table 108. Shanxi PUDE Pharmaceutical Recent Development Table 109. Shenzhen Main Luck Pharmaceuticals Company Information Table 110. Shenzhen Main Luck Pharmaceuticals Business Overview Table 111. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product Portfolio Table 113. Shenzhen Main Luck Pharmaceuticals Recent Development Table 114. Teva Company Information Table 115. Teva Business Overview Table 116. Teva Doxorubicin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Teva Doxorubicin Hydrochloride Product Portfolio Table 118. Teva Recent Development Table 119. North America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. North America Doxorubicin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 121. North America Doxorubicin Hydrochloride Sales Market Share by Country (2021-2026) Table 122. North America Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 123. North America Doxorubicin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 124. North America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Doxorubicin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Doxorubicin Hydrochloride Market Share by Country (2021-2026) Table 127. North America Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Doxorubicin Hydrochloride Market Share Forecast by Country (2027-2032) Table 129. Europe Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Europe Doxorubicin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 131. Europe Doxorubicin Hydrochloride Sales Market Share by Country (2021-2026) Table 132. Europe Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 133. Europe Doxorubicin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Doxorubicin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Doxorubicin Hydrochloride Market Share by Country (2021-2026) Table 137. Europe Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Doxorubicin Hydrochloride Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Doxorubicin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 141. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 143. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Doxorubicin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Doxorubicin Hydrochloride Market Share by Country (2021-2026) Table 147. Asia-Pacific Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Doxorubicin Hydrochloride Market Share Forecast by Country (2027-2032) Table 149. Latin America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Latin America Doxorubicin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 151. Latin America Doxorubicin Hydrochloride Sales Market Share by Country (2021-2026) Table 152. Latin America Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 153. Latin America Doxorubicin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Doxorubicin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Doxorubicin Hydrochloride Market Share by Country (2021-2026) Table 157. Latin America Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Doxorubicin Hydrochloride Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Doxorubicin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 161. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 163. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Doxorubicin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Doxorubicin Hydrochloride Market Share by Country (2021-2026) Table 167. Middle East and Africa Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Doxorubicin Hydrochloride Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Doxorubicin Hydrochloride Distributors List Table 172. Doxorubicin Hydrochloride Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Doxorubicin Hydrochloride Image Figure 2. Global Doxorubicin Hydrochloride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Doxorubicin Hydrochloride Market Size (2021-2032) & (US$ Million) Figure 4. Global Doxorubicin Hydrochloride Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg Image Figure 8. Global 20mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 50mg Image Figure 10. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 200mg Image Figure 12. Global 200mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Doxorubicin Hydrochloride Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Doxorubicin Hydrochloride Market Share by Type 2025 VS 2032 Figure 17. North America Doxorubicin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 18. North America Doxorubicin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 19. Europe Doxorubicin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 20. Europe Doxorubicin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 23. Latin America Doxorubicin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Doxorubicin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Doxorubicin Hydrochloride Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Malignant Lymphoma Image Figure 30. Global Malignant Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Lung Cancer Image Figure 32. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Acute Leukemia Image Figure 34. Global Acute Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 35. Breast Cancer Image Figure 36. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Doxorubicin Hydrochloride Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Doxorubicin Hydrochloride Market Share by Application 2025 VS 2032 Figure 41. North America Doxorubicin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 42. North America Doxorubicin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 43. Europe Doxorubicin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 44. Europe Doxorubicin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Doxorubicin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 47. Latin America Doxorubicin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Doxorubicin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Doxorubicin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 51. North America Doxorubicin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Doxorubicin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Doxorubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Doxorubicin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Doxorubicin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Doxorubicin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Doxorubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Doxorubicin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Doxorubicin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Doxorubicin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Doxorubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Doxorubicin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Doxorubicin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Doxorubicin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Doxorubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Doxorubicin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Doxorubicin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Doxorubicin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Doxorubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Doxorubicin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Doxorubicin Hydrochloride Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Doxorubicin Hydrochloride Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 20mg
  • 50mg
  • 200mg
  • Others
Applications
  • Malignant Lymphoma
  • Lung Cancer
  • Acute Leukemia
  • Breast Cancer
  • Others
Companies covered
  • Medac GmbH
  • Sun Pharmaceutical
  • Viatris
  • Fresenius Kabi
  • Zhejiang Hisun (HanHui Pharmaceuticals)
  • Pfizer
  • Shanxi PUDE Pharmaceutical
  • Shenzhen Main Luck Pharmaceuticals
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Doxorubicin Hydrochloride Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Doxorubicin Hydrochloride Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Doxorubicin Hydrochloride Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 20mg
  8. 1.3.3 50mg
  9. 1.3.4 200mg
  10. 1.3.5 Others
  11. 1.4 Global Doxorubicin Hydrochloride Market Size by Type
  12. 1.4.1 Global Doxorubicin Hydrochloride Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Doxorubicin Hydrochloride Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Doxorubicin Hydrochloride Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Doxorubicin Hydrochloride Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Doxorubicin Hydrochloride Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Doxorubicin Hydrochloride Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Doxorubicin Hydrochloride Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Doxorubicin Hydrochloride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Doxorubicin Hydrochloride Industry Trends
  2. 2.2 Doxorubicin Hydrochloride Industry Drivers
  3. 2.3 Doxorubicin Hydrochloride Industry Opportunities and Challenges
  4. 2.4 Doxorubicin Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Doxorubicin Hydrochloride Revenue (2021-2026)
  2. 3.2 Global Top Players by Doxorubicin Hydrochloride Sales (2021-2026)
  3. 3.3 Global Top Players by Doxorubicin Hydrochloride Price (2021-2026)
  4. 3.4 Global Doxorubicin Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Doxorubicin Hydrochloride Major Company Production Sites & Headquarters
  6. 3.6 Global Doxorubicin Hydrochloride Company, Product Type & Application
  7. 3.7 Global Doxorubicin Hydrochloride Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Doxorubicin Hydrochloride Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Doxorubicin Hydrochloride Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Doxorubicin Hydrochloride Tier 1, Tier 2, and Tier 3
4 Doxorubicin Hydrochloride Regional Status and Outlook
  1. 4.1 Global Doxorubicin Hydrochloride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Doxorubicin Hydrochloride Historic Market Size by Region
  3. 4.2.1 Global Doxorubicin Hydrochloride Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Doxorubicin Hydrochloride Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Doxorubicin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Doxorubicin Hydrochloride Forecasted Market Size by Region
  7. 4.3.1 Global Doxorubicin Hydrochloride Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Doxorubicin Hydrochloride Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Doxorubicin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Doxorubicin Hydrochloride by Application
  1. 5.1 Doxorubicin Hydrochloride Market by Application
  2. 5.1.1 Malignant Lymphoma
  3. 5.1.2 Lung Cancer
  4. 5.1.3 Acute Leukemia
  5. 5.1.4 Breast Cancer
  6. 5.1.5 Others
  7. 5.2 Global Doxorubicin Hydrochloride Market Size by Application
  8. 5.2.1 Global Doxorubicin Hydrochloride Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Doxorubicin Hydrochloride Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Doxorubicin Hydrochloride Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Doxorubicin Hydrochloride Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Doxorubicin Hydrochloride Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Doxorubicin Hydrochloride Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Doxorubicin Hydrochloride Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Doxorubicin Hydrochloride Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medac GmbH
  2. 6.1.1 Medac GmbH Company Information
  3. 6.1.2 Medac GmbH Business Overview
  4. 6.1.3 Medac GmbH Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medac GmbH Doxorubicin Hydrochloride Product Portfolio
  6. 6.1.5 Medac GmbH Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Doxorubicin Hydrochloride Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Viatris
  14. 6.3.1 Viatris Company Information
  15. 6.3.2 Viatris Business Overview
  16. 6.3.3 Viatris Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viatris Doxorubicin Hydrochloride Product Portfolio
  18. 6.3.5 Viatris Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Doxorubicin Hydrochloride Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Zhejiang Hisun (HanHui Pharmaceuticals)
  26. 6.5.1 Zhejiang Hisun (HanHui Pharmaceuticals) Company Information
  27. 6.5.2 Zhejiang Hisun (HanHui Pharmaceuticals) Business Overview
  28. 6.5.3 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product Portfolio
  30. 6.5.5 Zhejiang Hisun (HanHui Pharmaceuticals) Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Doxorubicin Hydrochloride Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Shanxi PUDE Pharmaceutical
  38. 6.7.1 Shanxi PUDE Pharmaceutical Company Information
  39. 6.7.2 Shanxi PUDE Pharmaceutical Business Overview
  40. 6.7.3 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product Portfolio
  42. 6.7.5 Shanxi PUDE Pharmaceutical Recent Developments
  43. 6.8 Shenzhen Main Luck Pharmaceuticals
  44. 6.8.1 Shenzhen Main Luck Pharmaceuticals Company Information
  45. 6.8.2 Shenzhen Main Luck Pharmaceuticals Business Overview
  46. 6.8.3 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product Portfolio
  48. 6.8.5 Shenzhen Main Luck Pharmaceuticals Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Doxorubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Doxorubicin Hydrochloride Product Portfolio
  54. 6.9.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Doxorubicin Hydrochloride Sales by Country
  2. 7.1.1 North America Doxorubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Doxorubicin Hydrochloride Sales by Country (2021-2026)
  4. 7.1.3 North America Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 7.2 North America Doxorubicin Hydrochloride Market Size by Country
  6. 7.2.1 North America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Doxorubicin Hydrochloride Market Size by Country (2021-2026)
  8. 7.2.3 North America Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Doxorubicin Hydrochloride Sales by Country
  2. 8.1.1 Europe Doxorubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Doxorubicin Hydrochloride Sales by Country (2021-2026)
  4. 8.1.3 Europe Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Doxorubicin Hydrochloride Market Size by Country
  6. 8.2.1 Europe Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Doxorubicin Hydrochloride Market Size by Country (2021-2026)
  8. 8.2.3 Europe Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Doxorubicin Hydrochloride Sales by Country
  2. 9.1.1 Asia-Pacific Doxorubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Doxorubicin Hydrochloride Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Doxorubicin Hydrochloride Market Size by Country
  6. 9.2.1 Asia-Pacific Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Doxorubicin Hydrochloride Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Doxorubicin Hydrochloride Sales by Country
  2. 10.1.1 South America Doxorubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Doxorubicin Hydrochloride Sales by Country (2021-2026)
  4. 10.1.3 South America Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 10.2 South America Doxorubicin Hydrochloride Market Size by Country
  6. 10.2.1 South America Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Doxorubicin Hydrochloride Market Size by Country (2021-2026)
  8. 10.2.3 South America Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Doxorubicin Hydrochloride Sales by Country
  2. 11.1.1 Middle East and Africa Doxorubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Doxorubicin Hydrochloride Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Doxorubicin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Doxorubicin Hydrochloride Market Size by Country
  6. 11.2.1 Middle East and Africa Doxorubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Doxorubicin Hydrochloride Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Doxorubicin Hydrochloride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Doxorubicin Hydrochloride Value Chain Analysis
  2. 12.1.1 Doxorubicin Hydrochloride Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Doxorubicin Hydrochloride Production Mode & Process
  7. 12.2 Doxorubicin Hydrochloride Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Doxorubicin Hydrochloride Distributors
  10. 12.2.3 Doxorubicin Hydrochloride Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst